Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
OMVOH
OMVOH
departments:
消化内科
drug:
注射液
Active:
MIRIKIZUMAB-MRKZ
indication:
OMVOHTM是一种白细胞介素-23拮抗剂,适用于治疗 成人中度至重度活动性溃疡性结肠炎。
Licensor:
Eli Lilly and Company
Approved Country/Region:
美国
Approval time:
2023-10-26